An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (8)
  • Training (0)
  • User case (0)
  • User meeting (0)
  • Webinar (2)
  • White paper (0)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (4)
  • Breast (1)
  • Gastro-intestinal (1)
  • (-) Genito-urinary (0)
  • Gynecological (0)
  • (-) Head and neck (10)
  • Hodgkin and Non-Hodgkin lymphoma (1)
  • Ocular (0)
  • Pediatric (1)
  • Reirradiation (0)
  • Sarcomas (0)
  • Thoracic (1)
  • Reset filters
  • (-) VMAT
  • (-) Genito-urinary
  • (-) Head and neck

Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in patients with nasopharyngeal carcinoma: A long-term, multicenter cohort study

19/02/2025
/ Publications
/
VMAT
Survival

Published in the Green Journal, this study from Taiwan compared treatment results of 276 patients with NPC treated with IMPT with a matched cohort of 276...

Intensity Modulated Proton Beam Therapy versus Volumetric Modulated Arc Therapy for Patients with Nasopharyngeal Cancer: A Propensity Score-Matched Study

08/07/2021
/ Publications
/
IMPT
VMAT

This study conducted a retrospective propensity score matching analysis (1:1) of 80 NPC patients treated with IMPT and VMAT. At a median follow-up time of 24.1...

Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.

03/03/2020
/ Publications
/
IMPT
Chemotherapy
VMAT

This study compared 46 IMPT and 259 VMAT patients acute toxicities and reported that IMPT was associated with lower PEG-tube placement (p = 0.001) and less...

A comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.

12/12/2021
/ Publications
/
IMPT
VMAT

A cohort of tonsil and salivary gland cancer patients who received ipsilateral curative-intent radiotherapy delivered by IMPT or VMAT were reviewed including...

Model-based for nasopharyngeal carcinoma (Spanish subtitles)

31/08/2020
/ Webinar
/
Model-based approach
IMPT
VMAT
ARC therapy

Prof. Hans Langendijk presents the model-based selection procedure for nasopharyngeal carcinoma, IMPT treatment results compared with IMRT or VMAT treatments...

PBT for Locally Advanced H&N Tumors: Analysis of Dosimetric and Clinical Outcomes

07/02/2022
/ Publications
/
VMAT

42 patients with locally advanced head and neck tumors treated with PBT were retrospectively analyzed in this study. Compared to VMAT plans, PBT plans showed a...

Post-Irradiation Sinus Mucosa Disease in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Proton Therapy.

07/01/2022
/ Publications
/
IMPT
VMAT

This study by the researchers from Taiwan compared the incidence and severity of chronic rhinosinusitis (CRS) in NPC patients who were treated with IMPT (n=53)...

Model-based for nasopharyngeal carcinoma

24/09/2020
/ Webinar
/
Model-based approach
VMAT
ARC therapy
IMRT
IMPT

Longitudinal Assessment of Quality of Life in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Proton Therapy and Volumetric Modulated Arc Therapy at Different Time Points.

06/05/2024
/ Publications
/
IMPT
Quality of life
VMAT

This is a longitudinal assessment of QoL on 287 NPC patients treated with IMPT (n=41) and VMAT (n=246). Both groups exhibited improved scores of global QoL...

A comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.

14/02/2022
/ Publications
/
IMPT
VMAT
Toxicity
ARC therapy

A cohort of tonsil and salivary gland cancer patients who received ipsilateral curative-intent radiotherapy delivered by IMPT or VMAT were reviewed. This study...

Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies